ATE118221T1 - Verwendung von tumornekrosefaktor. - Google Patents

Verwendung von tumornekrosefaktor.

Info

Publication number
ATE118221T1
ATE118221T1 AT91200520T AT91200520T ATE118221T1 AT E118221 T1 ATE118221 T1 AT E118221T1 AT 91200520 T AT91200520 T AT 91200520T AT 91200520 T AT91200520 T AT 91200520T AT E118221 T1 ATE118221 T1 AT E118221T1
Authority
AT
Austria
Prior art keywords
necrosis factor
tumor necrosis
disease
demyelinatig
uveitis
Prior art date
Application number
AT91200520T
Other languages
English (en)
Inventor
Yoshiki Otsuka
Kazuyoshi Hori
Hiroshi Hayashi
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2056736A external-priority patent/JPH03261725A/ja
Priority claimed from JP2056734A external-priority patent/JPH03261726A/ja
Priority claimed from JP2056735A external-priority patent/JPH03261724A/ja
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE118221T1 publication Critical patent/ATE118221T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Telephonic Communication Services (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT91200520T 1990-03-09 1991-03-08 Verwendung von tumornekrosefaktor. ATE118221T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2056736A JPH03261725A (ja) 1990-03-09 1990-03-09 移植片対宿主の疾患治療用医薬組成物
JP2056734A JPH03261726A (ja) 1990-03-09 1990-03-09 ぶどう膜炎治療用医薬組成物
JP2056735A JPH03261724A (ja) 1990-03-09 1990-03-09 脱髄性疾患治療用医薬組成物

Publications (1)

Publication Number Publication Date
ATE118221T1 true ATE118221T1 (de) 1995-02-15

Family

ID=27296018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91200520T ATE118221T1 (de) 1990-03-09 1991-03-08 Verwendung von tumornekrosefaktor.

Country Status (11)

Country Link
US (1) US5190750A (de)
EP (1) EP0445894B1 (de)
AT (1) ATE118221T1 (de)
AU (1) AU633196B2 (de)
CA (1) CA2037831C (de)
DE (2) DE69107226T2 (de)
DK (1) DK0445894T3 (de)
ES (1) ES2067842T3 (de)
FR (1) FR2659235A1 (de)
GB (1) GB2241891B (de)
GR (1) GR3015840T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5080393A (en) * 1992-08-17 1994-03-15 Autoimmune, Inc. Bystander suppression of retroviral-associated neurological disease
EP0752879A4 (de) * 1994-04-08 1999-07-21 Brigham & Womens Hospital Behandlung von autoimmun-krankheiten mittels oraler tolerierung und/oder th2-erhöhenden cytokinen
NZ508878A (en) * 1998-05-15 2003-08-29 Genentech Inc IL-17B and IL-17Cactive variants of IL-17 which stimulates epithelial, endothelial and fibroblastic cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292727A (ja) * 1986-06-12 1987-12-19 Dainippon Pharmaceut Co Ltd 癌壊死因子を有効成分とする鎮痛・消炎剤
JPS6330426A (ja) * 1986-07-25 1988-02-09 Mitsubishi Chem Ind Ltd 自己免疫性疾患治療薬
DE3631413A1 (de) * 1986-09-16 1988-03-24 Knoll Ag Therapeutisches system zur lokalen applikation von pharmawirkstoffen
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US4963354A (en) * 1987-01-21 1990-10-16 Genentech, Inc. Use of tumor necrosis factor (TNF) as an adjuvant
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
AU2844889A (en) * 1988-01-22 1989-07-27 Collagen Corporation Method for suppressing the growth of normal and cancer cells
DE3839639A1 (de) * 1988-11-24 1990-05-31 Basf Ag Verwendung von tnf bei der behandlung von hautkrankheiten
CA2003981C (en) * 1988-12-27 2000-06-13 Hiroshi Ishimaru Pharmaceutical compositions and use thereof in the treatment of psoriasis

Also Published As

Publication number Publication date
DK0445894T3 (da) 1995-04-03
ES2067842T3 (es) 1995-04-01
EP0445894A2 (de) 1991-09-11
US5190750A (en) 1993-03-02
GB2241891A (en) 1991-09-18
CA2037831A1 (en) 1991-09-10
GB2241891B (en) 1994-05-25
EP0445894A3 (en) 1992-01-02
AU7281091A (en) 1991-09-12
DE4107554A1 (de) 1991-10-10
EP0445894B1 (de) 1995-02-08
GR3015840T3 (en) 1995-07-31
CA2037831C (en) 1997-01-21
DE69107226D1 (de) 1995-03-23
DE69107226T2 (de) 1995-05-24
AU633196B2 (en) 1993-01-21
FR2659235A1 (fr) 1991-09-13
GB9104927D0 (en) 1991-04-24

Similar Documents

Publication Publication Date Title
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE69426334T2 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
DE69706825D1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
ATE165514T1 (de) Verwendung von inosittriphosphat zur zubereitung von medikamenten
DE69429591D1 (de) Therapeutisch wirksame Verbindungen
CA2041417A1 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
CA2046069A1 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DK658889D0 (da) Farmaceutisk praeparat til brug ved behandling af psoriasis
DE69107226D1 (de) Verwendung von Tumornekrosefaktor.
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
AU658197B2 (en) New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
IT1248669B (it) Derivato di idrossiprolina, sua preparazione e composizioni farmaceutiche che lo contengono
RU93004721A (ru) Сульфонамидные соединения, способ их получения и фармацевтическая композиция

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee